Tag: SGLT2 inhibitor risks
Canagliflozin Amputation Risk: What You Need to Know Now
Canagliflozin (INVOKANA) carries a real but manageable risk of foot amputations in people with diabetes. Learn who's most at risk, how to prevent complications, and why other SGLT2 inhibitors may be safer alternatives.